SCHEMBL3768083

SCHEMBL3768083

CCC=CCOc1cccc(CN)c1F

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 2/20 0.38
CTSS P25774 3/20 0.37
CTSK P43235 3/20 0.37
CTSL P07711 2/20 0.37
RPS6KA1 Q15418 1/20 0.36
AOC3 Q16853 1/20 0.34
MAOB P27338 2/20 0.33
HRH1 P35367 1/20 0.33
CD274 Q9NZQ7 1/20 0.32
MAPT P10636 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
ALDH1A1 P00352 1/20 0.31
PNMT P11086 1/20 0.31
HTR2A P28223 2/20 0.31
LTA4H P09960 1/20 0.30
PLA2G2A P14555 1/20 0.30
TRPM8 Q7Z2W7 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3769104 0.88 CTSS (0.39) TAAR1CTSSCTSKCTSLRPS6KA1
SCHEMBL3764641 0.86 TAAR1 (0.39) TAAR1CTSSCTSKCTSLRPS6KA1
SCHEMBL3763441 0.85 CYSLTR2 (0.38) TAAR1CTSSCTSKCTSLRPS6KA1
SCHEMBL3772715 0.85 RPS6KA1 (0.34) TAAR1RPS6KA1MAOBMAPTL3MBTL1
SCHEMBL3771175 0.84 CYSLTR2 (0.42) CTSSCTSKCTSLMAPT
SCHEMBL3771934 0.84 L3MBTL1 (0.39) TAAR1RPS6KA1MAPTL3MBTL1
SCHEMBL3770876 0.82 L3MBTL1 (0.38) RPS6KA1MAPTL3MBTL1
SCHEMBL3766260 0.79 MAPT (0.49) MAPTL3MBTL1ALDH1A1HTR2A
SCHEMBL3768078 0.77 CTSS (0.34) CTSSCTSKCTSLL3MBTL1ALDH1A1
SCHEMBL3659486 0.77 CTSS (0.34) CTSSCTSKCTSLL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 TAAR1 773/4885CTSS 2078/4885CTSK 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.